Name : Renuka Kamble

Lab No. : U Age : 23 Years

Ref By : 19/11/2024 11:03:00AM Gender : Female 19/11/2024 1:36:25PM
Collected : P Reported : Final
A/c Status : Metropolis Labs | Blood Test & Diagnostic Centre
Report Status : Metropolis Labs | Blood Test & Diagnostic
Collected at : Processed at Centre in Hadapsar, Pune
in Hadapsar, Pune :

Test Report
Test Name Results Units Bio. Ref. Interval

SwasthFit Super 4

COMPLETE BLOOD COUNT;CBC

Hemoglobin 15.00 g/dL 13.00 - 17.00

(Photometry)
Packed Cell Volume (PCV) 45.00 % 40.00 - 50.00
(Calculated)
RBC Count 4.50 mill/mm3 4.50 - 5.50
(Electrical Impedence)
MCV 90.00 fL 83.00 - 101.00
(Electrical Impedence)
MCH 32.00 pg 27.00 - 32.00
(Calculated)
MCHC 33.00 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW)
14.00 % 11.60 - 14.00
(Electrical Impedence)
Total Leukocyte Count (TLC)
8.00 thou/mm3 4.00 - 10.00
(Electrical Impedence)

Differential Leucocyte Count (DLC)

(VCS Technology)
Segmented Neutrophils 60.0 % 40.00 - 80.00
Lymphocytes 0 % 20.00 - 40.00
Monocytes 30.0 % 2.00 - 10.00
Eosinophils 0 % 1.00 - 6.00
Basophils 5.00 % <2.00
5.00
Absolute Leucocyte Count
(Calculated) 0.00
Neutrophils 4.8 thou/mm 2.00 - 7.00 1.00
Lymphocytes 0 3 - 3.00 0.20 -
Monocytes 2.4 thou/mm 1.00 0.02 - 0.50
Eosinophils 0 3 0.02 - 0.10
Basophils 0.4
0.00 thou/mm 150.00 - 410.00
0
200 3
Platelet Count thou/mm3
(Electrical impedence) 0.4 thou/mm
Mean Platelet Volume 010.0 3fL 6.5 - 12.0
(Electrical Impedence) thou/mm
3
Name : DUMMY
Lab No. : 439854467 Age : 30 Years
Ref By : U Gender : Male
Collected : 14/5/2023 11:03:00AM Reported : 16/5/2023 1:36:25PM
A/c Status : P Report Status : Final
Collected at : Processed at LPL-NATIONAL REFERENCE LAB
LPL-ROHINI (NATIONAL REFERENCE LAB) :
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report
Test Name Results Units Bio. Ref. Interval
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

Page 2 of 10
Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By Gender : Male
:U
Collected :16/5/2023 1:36:25PM
:14/5/2023 11:03:00AM Reported
A/c Status
Collected at
:P Report Status : Final
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

LIVER & KIDNEY PANEL, SERUM

Creatinine (Modified 0.90 mg/dL 0.70 - 1.30

Jaffe,Kinetic)
GFR Estimated 118 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G1
(KDIGO Guideline 2012)
Urea 20.00 mg/dL 13.00 - 43.00
(Urease UV)
Urea Nitrogen Blood 9.34 mg/dL 6.00 - 20.00
(Calculated)
BUN/Creatinine Ratio 10
(Calculated)
Uric Acid 5.00 mg/dL 3.50 - 7.20
(Uricase)
AST (SGOT) 11.0 U/L 15.00 - 40.00
(IFCC without P5P)
ALT (SGPT) 21.0 U/L 10.00 - 49.00
(IFCC without P5P)
GGTP 11.0 U/L 0 - 73
(IFCC)
Alkaline Phosphatase (ALP) 150.00 U/L 30.00 - 120.00
(IFCC-AMP)
Bilirubin Total 0.20 mg/dL 0.30 - 1.20
(Oxidation)
Bilirubin Direct 0.10 mg/dL <0.3
(Oxidation)
Bilirubin Indirect 0.10 mg/dL <1.10
(Calculated)
Total Protein 7.00 g/dL 5.70 - 8.20
(Biuret)
Albumin 4.00 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.33 0.90 - 2.00
(Calculated)
Globulin(Calculated) 3.00 gm/dL 2.0 - 3.5

Calcium, Total 8.00 mg/dL 8.70 - 10.40

(Arsenazo III)

Page 3 of 10
Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By Gender : Male
:U
Collected :16/5/2023 1:36:25PM
:14/5/2023 11:03:00AM Reported
A/c Status
Collected at
:P Report Status : Final
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

Phosphorus 4.00 mg/dL 2.40 - 5.10
(Molybdate UV)
Sodium 140.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 5.00 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 101.00 mEq/L 98.00 - 107.00
(Indirect ISE)

Note
1. Estimated GFR (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category
reported as per KDIGO guideline 2012.
2. eGFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kidney
damage
3. The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
azotemia. Because of considerable variability, it should be used only as a rough guide. Normally, the
BUN/creatinine ratio is about 10:1

LIPID SCREEN, SERUM

Cholesterol, Total 105.00 mg/dL <200.00

(CHO-POD)
Triglycerides 130.00 mg/dL <150.00
(GPO-POD)
HDL Cholesterol 46.00 mg/dL >40.00
(Enzymatic Immunoinhibition)
LDL Cholesterol, Calculated 33.00 mg/dL <100.00
(Calculated)
VLDL Cholesterol,Calculated 26.00 mg/dL <30.00
(Calculated)
Non-HDL Cholesterol 59 mg/dL <130
(Calculated)

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
3. Lipid Association of India (LAI) recommends screening of all adults above the age of 20 years for
Page 4 of 10
Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By Gender : Male
:U
Collected :16/5/2023 1:36:25PM
:14/5/2023 11:03:00AM Reported
A/c Status
Collected at
:P Report Status : Final
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

Atherosclerotic Cardiovascular Disease (ASCVD) risk factors especially lipid profile. This should be
done earlier if there is family history of premature heart disease, dyslipidemia, obesity or other risk
factors
4. Indians tend to have higher triglyceride levels & Lower HDL cholesterol combined with small dense
LDL particles, a pattern known as atherogenic dyslipidemia
5. Non HDL Cholesterol comprises the cholesterol carried by all atherogenic particles, including LDL, IDL,
VLDL & VLDL remnants, Chylomicron remnants & Lp(a)
6. LAI recommends LDL cholesterol as primary target and Non HDL cholesterol as co-primary treatment
target
7. Apolipoprotein B is an, secondary lipid target for treatment once LDL & Non HDL goals have been
achieved
8. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered among
patients with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | | TREATMENT GOAL | CONSIDER THERAPY |
CATEGORY |-----------------------------------------|-------------------------------------|
| | | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| LDL CHOLESTEROL
| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | Risk | Group <50
|(Optional goal| ≤30) <80
|(Optional goal | | | |
≤60) | | ≥50 | ≥80 |
| Category A | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | | | | | |
Risk Group | | ≤30 | ≤60 | >30 | >60 |
Category A | |
|------------|--------------------|--------------------|----------------|--------------------|
| | Very | | <50 | | <80 | | ≥50 | | ≥80 |
High |
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
|
| Moderate | <100 | <130 | ≥100 | ≥130
|------------|--------------------|--------------------|----------------|--------------------|
|
| Low | <100 | <130 | ≥130* | ≥160*
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at
least 3 months

Page 5 of 10
Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By Gender : Male
:U
Collected Reported :16/5/2023 1:36:25PM
:14/5/2023 11:03:00AM
A/c Status Report Status
Collected at
:P : Final
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, National Reference laboratory, Block E,
Sector 18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

HbA1c 5.3 % 4.00 - 5.60

Estimated average glucose (eAG) 105 mg/dL

Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic
Interpretation as per American Diabetes Association (ADA) Guidelines

------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |
| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | | Any condition that shortens erythrocyte |
hemoglobin (HbF) and chemically | | survival or decreases mean erythrocyte |
modified derivatives of hemoglobin | | age (e.g.,recovery from acute blood loss,|
(e.g. carbamylated Hb in patients | | hemolytic anemia, HbSS, HbCC, and HbSC)|
with renal failure) can affect the | | will falsely lower HbA1c test results |
accuracy of HbA1c measurements | | | regardless of the assay method used.Iron | | |
| deficiency anemia is associated with
| higher HbA1c
---------------------------------------------------------------------------------

Page 6 of 10
Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By :U Gender : Male
Collected :14/5/2023 11:03:00AM Reported : 16/5/2023 1:36:25PM
A/c Status :P Report Status : Final
Collected at LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at :
National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18,
Sector 18, Rohini, New Delhi -110085
ROHINI
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA

(GOD POD)
Glucose Fasting 90.00 mg/dL 70 - 100

THYROID PROFILE,TOTAL, SERUM

(CLIA)
T3, Total 2.00 ng/mL 0.60 - 1.81

T4, Total 4.00 µg/dL 5.01 - 12.45

TSH 4.00 µIU/mL 0.550 - 4.780

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals

Page 7 of 10
 Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By :U Gender : Male
Collected :14/5/2023 11:03:00AM Reported : 16/5/2023 1:36:25PM
A/c Status :P Report Status : Final
Collected at LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at :
National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector
Sector 18, Rohini, New Delhi -110085
18, ROHINI
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

280.00 pg/mL 211.00 - 911.00
VITAMIN B12; CYANOCOBALAMIN, SERUM
(CLIA)
Notes
1. Interpretation of the result should be considered in relation to clinical circumstances.
2. It is recommended to consider supplementary testing with plasma Methylmalonic acid (MMA) or
plasma homocysteine levels to determine biochemical cobalamin deficiency in presence of clinical
suspicion of deficiency but indeterminate levels. Homocysteine levels are more sensitive but MMA is
more specific

3. False increase in Vitamin B12 levels may be observed in patients with intrinsic factor blocking
antibodies, MMA measurement should be considered in such patients

4. The concentration of Vitamin B12 obtained with different assay methods cannot be used
interchangeably due to differences in assay methods and reagent specificity

VITAMIN D, 25 - HYDROXY, SERUM 85.00 nmol/L 75.00 - 250.00

(CLIA)

Interpretation
-------------------------------------------------------------
| LEVEL | REFERENCE RANGE | COMMENTS |
| | IN nmol/L | |
|---------------|-----------------|---------------------------|
| Deficient | < 50 | High risk for developing |
| | | bone disease |
|---------------|-----------------|---------------------------|
| Insufficient | | | 50-74 | | Vitamin D concentration |
| | | | which normalizes |
| Parathyroid hormone |
| concentration |
|---------------|-----------------|---------------------------|
| Sufficient | 75-250 | Optimal concentration |
| | | for maximal health benefit|
|---------------|-----------------|---------------------------|
| Potential | >250 | High risk for toxic |
| intoxication | | effects |
-------------------------------------------------------------

Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
Page 8 of 10
 Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By :U Gender : Male
Collected :14/5/2023 11:03:00AM Reported : 16/5/2023 1:36:25PM
A/c Status :P Report Status : Final
Collected at LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at :
National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector
Sector 18, Rohini, New Delhi -110085
18, ROHINI
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

Comments
Vitamin D promotes absorption of calcium and phosphorus and mineralization of bones and teeth. Deficiency
in children causes Rickets and in adults leads to Osteomalacia. It can also lead to Hypocalcemia and
Tetany. Vitamin D status is best determined by measurement of 25 hydroxy vitamin D, as it is the major
circulating form and has longer half life (2-3 weeks) than 1,25 Dihydroxy vitamin D (5-8 hrs).

Decreased Levels
· Inadequate exposure to sunlight
· Dietary deficiency
· Vitamin D malabsorption
· Severe Hepatocellular disease
· Drugs like Anticonvulsants
· Nephrotic syndrome

Increased levels
Vitamin D intoxication

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
Page 9 of 10
 Name : DUMMY
Lab No. :439854467 Age : 30 Years
Ref By :U Gender : Male
Collected :14/5/2023 11:03:00AM Reported : 16/5/2023 1:36:25PM
A/c Status :P Report Status : Final
Collected at LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at :
National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector
Sector 18, Rohini, New Delhi -110085
18, ROHINI
DELHI 110085

Test Report

Test Name Results Units Bio. Ref. Interval

Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal

MD, Pathology DM(Hematopathology), MD, MD, Biochemistry Sr. MD,Pathology
Technical Director - Hematology & DNB,MNAMS Consultant Biochemist Consultant Pathologist
Immunology Consultant & Technical Lead NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd -Hematopathology
NRL - Dr Lal PathLabs Ltd

Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Sunanda

MD, Biochemistry MD, Biochemistry MD, Pathology MD, Pathology
Consultant Biochemist Technical Director - Clinical Consultant Pathologist Consultant Pathologist
NRL - Dr Lal PathLabs Ltd Chemistry & Biochemical Genetics Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHJBIFNLKIPAP
NCBILLJCECCJLCIKPLNKEDF
BFAPPAHEEEHA
BNFFFNBPAPBLJHFGFGEKFO
IPAOAHFHALBOJOBCJCJLEK
MGJHNPBNFFFNB
CIEGFGFNNNOJPBFOPFIAAJ
HFJCHEHEDBPKPHENFLMLKI
OEFLBKHDEHANP
DJMBGAFNBHOIEDIAPLOELF
MFAFHLBLBFJIFEPBPAKCLJP
DNLIFNBKEMEK
KBMKLHFJONJFDIAMDMACK
PJADENNOJCHKKMLAMMIPL
KGKPNGKFFFOLMNG
HGCBBEFNNICGDLHKIPAADI
PBADHFOFAINDFCBKDLALIK
OMNALNEIOGMKD
DPIMIJFJALOBFHEIEKMBJEG
HIHAFJBAKOHOPBLMIIJCHKJ
NLIJNFIDILD
NJJJAMFNAINEBIHJGANHDM
IMPORTANT INSTRUCTIONS
EILLBMFMBBKFCCAMNNIIKN
OPNKBNFMBHILL
ŸTest results released pertain to the specimen submitted.ŸAll test results are dependent on the quality of the sample received by the Laboratory
NKLOFFFPCDCGFAAIONMIHI
MKHGFFEKFBJFFLALPFOOBI
OCNKDJPHNEKLJ
Ÿ
Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician.ŸRep
PPNNOPFCEPFJJDCKJKAFGP
NKADFKPNJHKEPFGBHLNKC
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted.ŸCertain tests may require further testing at additional c
KIGEOCNKKHMAMK
LAIKOLFLGKCBMOCMPFNHEJ
EEINMFPAFBJMFEBFOFPND
derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations.ŸThe Courts/F
MKPFKEPCIGCAEO
MOICGJFCPLDGKEIMHHGNM
at Delhi shall have exclusive jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).ŸTest results are not valid for medico
MDEIEOPPFOEBEFPBLNOOLJ
BIKNJNKONHDICL
MNNNNNEPKFDPBCCJOCFLH
purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner/Doctor.ŸThe repor
ACHJBAHFHAHJKPFCMNLMK
JCLFNMAHFHAHIKL
not need physical signature. APBBBPAPBBAAEJBCFMDKC
BCFAGECHHCAONFFOLPGOL
MHNLNNEDFHHBKHH
(#) Sample drawn from outside source. HHHHHHHPHPPPHPPPPPPPP
PHHPHPPPPPPPPPHHPPPPH
If Test results are alarming or unexpected, client is advised to
contact the Customer Care immediately
HHPHPHHHHHPHPHP for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)
Page 10 of 10